NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Categories: Multiple Sclerosis

10/16/2017

UCSF offers cautious recap but equates surrogate markers with clinical outcomes in MS drug study

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

8/15/2016

Do statistically insignificant outcomes in multiple sclerosis treatment study deserve a news release?

1 6/20/2016

Ottawa Hospital release on MS therapy hits the right notes with clarity and cautions

4/19/2016

Data absent from claim that video game benefits MS patients

12/13/2015

Engaging UCLA release suggests pregnancy hormone may benefit MS patients – but lacks key data

1 4/27/2015

Exaggeration at the NIH? Mouse study release may go too far in suggesting “reversal” of multiple sclerosis